% Expired Patents = 25.0

EPO Patents = 1

Forward Citations = 6

Loading Chart...

2 inventors (with patents filed for the assignee):

Tom Yao-Hsiang Wu (4 out of 24 patents)

Andrew T Miller (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 11173157 - Substituted pyrimidines containing acidic groups as TLR7 modulators (2021-11-16),

2. 10857153 - Pyrimidine compounds containing acidic groups (2020-12-08),

3. 10786502 - Substituted pyrimidines containing acidic groups as TLR7 modulators (2020-09-29),

4. 10287253 - Substituted pyrimidines containing acidic groups as TLR7 modulators (2019-05-14),

Company Overview

Apros Therapeutics, Inc. is a biopharmaceutical company focused on the development of novel therapeutics for the treatment of autoimmune and inflammatory diseases. Our mission is to improve the lives of patients through innovative research and drug development. With a strong pipeline of drug candidates, we are committed to bringing new treatment options to those in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#1,006 in San Diego, CA

#14,041 in California

#60,597 in US

San Diego, CA, United States of America

Apros Therapeutics, Inc.

Forward Citations = 6

2 inventors:

Tom Yao-Hsiang Wu (4 out of 24 patents)

Andrew T Miller (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apros Therapeutics, Inc.. Retrieved from https://idiyas.com/company/apros-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]